We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Impax in ‘Precarious Position’ as Key Products Face Competition: Analyst
Impax in ‘Precarious Position’ as Key Products Face Competition: Analyst
November 6, 2012
Impax Laboratories’ reliance on a few key products — two generics and one brand drug — for the bulk of its revenue is likely to hurt the company in the near future as it loses its near monopoly on the drugs.